DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 022504
The generic ingredient in AXIRON is testosterone. There are sixty-three drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the testosterone profile page.
Summary for 022504
Tradename: | AXIRON |
Applicant: | Eli Lilly And Co |
Ingredient: | testosterone |
Patents: | 7 |
Therapeutic Class: | Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers) |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 022504
Ingredient-type | Androstanes |
Mechanism of Action | Androgen Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 022504
Suppliers and Packaging for NDA: 022504
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504 | NDA | Eli Lilly and Company | 0002-1975 | N | 0002-1975-61 |
AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504 | NDA | Eli Lilly and Company | 0002-1975 | N | 0002-1975-90 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION, METERED;TRANSDERMAL | Strength | 30MG/1.5ML ACTUATION | ||||
Approval Date: | Nov 23, 2010 | TE: | RLD: | Yes | |||||
Patent: | ➤ Sign Up | Patent Expiration: | Feb 26, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF A PERSON IN NEED THEREOF | ||||||||
Patent: | ➤ Sign Up | Patent Expiration: | Sep 27, 2027 | Product Flag? | Substance Flag? | Delist Request? | |||
Patented Use: | A METHOD OF INCREASING THE TESTOSTERONE BLOOD LEVEL OF AN ADULT MALE SUBJECT IN NEED THEREOF | ||||||||
Patent: | ➤ Sign Up | Patent Expiration: | Jul 13, 2023 | Product Flag? | Y | Substance Flag? | Delist Request? | ||
Patented Use: | A METHOD OF TRANSDERMALLY DELIVERING TESTOSTERONE |
Expired US Patents for NDA 022504
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | ➤ Sign Up | ➤ Sign Up |
Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | ➤ Sign Up | ➤ Sign Up |
Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | ➤ Sign Up | ➤ Sign Up |
Eli Lilly And Co | AXIRON | testosterone | SOLUTION, METERED;TRANSDERMAL | 022504-001 | Nov 23, 2010 | ➤ Sign Up | ➤ Sign Up |
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Complete Access Available with Subscription